Soliton, Inc. (SOLY) |
| 22.58 0 (0%) 04-24 15:47 |
| Open: | 22.56 |
| High: | 22.59 |
| Low: | 22.56 |
| Volume: | 1,347,169 |
| Market Cap: | 0(M) |
| PE Ratio: | 0 |
| Exchange: | NASDAQ Capital Market |
| Industry: | Medical - Devices |
| Sector: | Healthcare |
| Technical analysis | ||||
| sell | buy | |||
| Resistance 2: | |
| Resistance 1: | |
| Pivot price: | |
| Support 1: | |
| Support 2: | |
| 52w High: | 22.6 |
| 52w Low: | 7.53 |
Soliton, Inc., a medical device company, develops and commercializes products using a proprietary rapid acoustic pulse technology platform. The company offers products for the removal of tattoos. It also develops a product for cellulite reduction, fibrotic scar treatment, and other indications. The company was incorporated in 2012 and is based in Houston, Texas. As of December 16, 2021, Soliton, Inc. operates as a subsidiary of Allergan plc.
Financials
| EPS | |
| Book Value | |
| PEG Ratio | |
| Gross Profit |
| Profit Margin (%) | |
| Operating Margin (%) | |
| Return on Assets (ttm) | |
| Return on Equity (ttm) |
Company news
Thu, 16 Dec 2021
Allergan Aesthetics Completes Acquisition of Soliton - PR Newswire
Mon, 24 May 2021
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates CNBKA, WRI, KNL, EBSB, SOLY; Shareholders are Encouraged to Contact the Firm - PR Newswire
Mon, 10 May 2021
Allergan Aesthetics to Acquire Soliton - citybiz
Wed, 05 May 2021
Introducing RESONIC™ - BioSpace
Wed, 24 Mar 2021
Soliton /Tx/ (SOLY) Stock Live Price, Chart & News - CoinCodex
Tue, 02 Mar 2021
Soliton Selects RESONIC™ As Brand Name for FDA-Cleared Rapid Acoustic Pulse Device - PR Newswire
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
